558467-56-4

Basic information

• Product Name: (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[[(tert-butyloxycarbonyl)-L-valinyl]amino]-5-hydroxy-7-phenylheptanoyl amide
• Synonyms: (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[[(tert-butyloxycarbonyl)-L-valinyl]amino]-5-hydroxy-7-phenylheptanoyl amide
• CAS NO: 558467-56-4
• Molecular Weight: 739.707
• Mol File: 558467-56-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[[(tert-butyloxycarbonyl)-L-valinyl]amino]-5-hydroxy-7-phenylheptanoyl amide(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[[(tert-butyloxycarbonyl)-L-valinyl]amino]-5-hydroxy-7-phenylheptanoyl amide(558467-56-4)
• EPA Substance Registry System: (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[[(tert-butyloxycarbonyl)-L-valinyl]amino]-5-hydroxy-7-phenylheptanoyl amide(558467-56-4)

Safety Data

• Hazardous Substances Data: 558467-56-4(Hazardous Substances Data)

Upstream product

• 13734-41-3 t-Boc-L-valine 
• 500767-24-8 (2S,5S,6S)-3-aza-3-(benzyloxycarbonyl)-2-(p-bromobenzyl)-6-[(tert-butyloxycarbonyl)amino]-5-hydroxy-7-phenylheptanoyl amide 
• 500767-17-9 (2S,5S,6S)-3-aza-2-(p-bromobenzyl)-6-[(tert-butyloxycarbonyl)amino]-5-hydroxy-7-phenylheptanoyl amide 
• 500767-10-2 (2S)-2-amino-3-(4-bromophenyl)propanamide 
• 99359-33-8 (S)-methyl 2-amino-3-(4-bromophenyl)propanoate 
• 24250-84-8 H-p-BrPhe-OH 
• 98760-08-8 (2R,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1,2-epoxy-4-phenylbutane 

Downstream Products

• 500767-08-8 Pyridine-2-carboxylic acid ((S)-1-{(1S,2S)-1-benzyl-3-[(S)-5-(4-bromo-benzyl)-2,4-dioxo-imidazolidin-1-yl]-2-hydroxy-propylcarbamoyl}-2-methyl-propyl)-amide 
• 500767-38-4 Pyridine-2-carboxylic acid ((S)-1-{(1S,2S)-1-benzyl-3-[(S)-2-(4-bromo-phenyl)-1-carbamoyl-ethylamino]-2-hydroxy-propylcarbamoyl}-2-methyl-propyl)-amide 

Relevant articles and documents

Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes

A series of protease inhibitors targeted at the malarial enzymes plasmepsin I and II, and encompassing a basic hydroxyethylamine transition state isostere scaffold, was prepared. The substituents in the P1′ position were varied and the biological activiti